Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IWWM-11 2022 | Insights into how COVID-19 will continue to impact patients with hematological malignancies

Lee Greenberger • 31 Oct 2022
IWWM-11 2022
General

Lee Greenberger, PhD, Leukemia & Lymphoma Society, New York, NY, discusses the challenges that patients with hematological malignancies will likely face as new strains of COVID-19 continue to emerge and the importance of monitoring these strains. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Lee Greenberger

Addressing cardiovascular AEs associated with BTKi treatment in patients with CLL
1:57
Addressing cardiovascular AEs associated with BTKi treatment in patients with CLL
Lee Greenberger • 9 Dec 2023
Real-world incidence of ibrutinib-related cardiotoxicity in CLL: insights from the LLS registry
2:09
Real-world incidence of ibrutinib-related cardiotoxicity in CLL: insights from the LLS registry
Lee Greenberger • 9 Dec 2023
COVID-19 vaccination response in patients with hematologic malignancies from the LLS Registry
7:41
COVID-19 vaccination response in patients with hematologic malignancies from the LLS Registry
Lee Greenberger • 11 Dec 2022
The importance of monitoring COVID-19 in patients with Waldenström’s macroglobulinemia
3:15
The importance of monitoring COVID-19 in patients with Waldenström’s macroglobulinemia
Lee Greenberger • 31 Oct 2022

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI for clinical decision-making
2:25
Addressing the risk of over-reliance on AI for clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals